NCT00004814
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
- Locations
-
Not specified
Clinical trial condition
Autoimmune Diseases of the Nervous System
Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.
3,224 public trials
544 recruiting studies
Autoimmune Diseases of the Nervous System trial results
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +11 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Colorado Cancer Center Denver, Colorado, United States
- Washington University Barnard Cancer Center St Louis, Missouri, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, Not Recruiting
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
NCT06149559
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0006 40290 Bologna, Italy
- Mg0006 40144 Milan, Italy
- Mg0006 40733 Naples, Italy
- Mg0006 20340 Fuchu-shi, Japan
Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
NCT04544436
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- North Central Neurology Associates Cullman, Alabama, United States
- Alabama Neurology Associates Homewood, Alabama, United States
- 21st Century Neurology Phoenix, Arizona, United States
- Profound Research, LLC Carlsbad, California, United States
Active, Not Recruiting
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- University of South Alabama Mobile, Alabama, United States
- Clinical Endpoints, LLC Scottsdale, Arizona, United States
- Profound Research - Neurology Center of Southern California Carlsbad, California, United States
- Mountain Neurological Research Center Basalt, Colorado, United States
Active, Not Recruiting
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
NCT06282159
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Clinical Study Site Phoenix, Arizona, United States
- Clinical Study Site Irvine, California, United States
- Clinical Study Site Stamford, Connecticut, United States
- Clinical Study Site Boca Raton, Florida, United States
Active, Not Recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
- Locations
-
- Alabama Neurology Associates Homewood, Alabama, United States
- 21st Century Neurology Phoenix, Arizona, United States
- University of California Irvine Irvine, California, United States
- Stanford University Medical Center Stanford, California, United States
Active, Not Recruiting
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
NCT03523858
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- MS Center of California Laguna Hills, California, United States
- SC3 Research Group, Inc Pasadena, California, United States
- University of California San Francisco San Francisco, California, United States
- University of South Florida Tampa, Florida, United States
Active, Not Recruiting
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
NCT04225871
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0011 41 Mobile, Alabama, United States
- Mg0011 116 Phoenix, Arizona, United States
- Mg0011 31 Irvine, California, United States
- MG0011 4 Los Angeles, California, United States
Active, Not Recruiting
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
NCT06141473
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- University of Alabama at Birmingham- Site Number : 8401135 Birmingham, Alabama, United States
- North Central Neurology Associates- Site Number : 8401100 Cullman, Alabama, United States
- Alabama Neurology Associates- Site Number : 8400115 Homewood, Alabama, United States
- St. Joseph's Hospital and Medical Center- Site Number : 8401139 Phoenix, Arizona, United States